Related Experiment Videos
Hypercoagulable states. Their causes and management
1Department of Medicine, Brooke Army Medical Center, Fort Sam Houston, TX 78234-6200.
Insights
Identifying patients with hypercoagulable states is crucial for preventing thrombosis. Early recognition through medical history and risk factors can reduce severe outcomes, with hereditary thrombosis requiring lifelong anticoagulation.
Area of Science:
- Internal Medicine
- Hematology
- Genetics
Background:
- Hypercoagulable states, both hereditary and acquired, increase the risk of thrombosis.
- Prompt identification and management are essential to prevent significant morbidity and mortality.
Purpose of the Study:
- To highlight the importance of recognizing patients who require evaluation for hypercoagulable states.
- To emphasize the role of comprehensive patient assessment in identifying at-risk individuals.
Main Methods:
- Review of medical history, including current medications.
- Assessment of family history for thrombotic events.
- Evaluation of circumstantial risk factors contributing to thrombosis.
Main Results:
- Thorough patient evaluation can identify individuals susceptible to thrombotic events.
- Timely intervention based on risk assessment can mitigate adverse outcomes.
Conclusions:
- Recognition of hereditary or acquired hypercoagulable states is vital for initiating appropriate treatment.
- Lifelong anticoagulation is recommended for patients diagnosed with hereditary thrombosis to prevent recurrent events.
Abstract:
Recognition of patients who should be evaluated for either hereditary or acquired hypercoagulable states is important so that treatment may be instituted if necessary to prevent thrombosis. Close attention to the medical history, medications, family history, and circumstantial risk factors can help identify patients at risk so that morbidity and mortality may be reduced. Patients with hereditary thrombosis should receive lifelong anticoagulation.